<<<<<<< Updated upstream
Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS) | Elite Sports MagSkip to content
Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)
The Training Science Trials Ledger follows ClinicalTrials.gov studies of exercise and training interventions, with training and population families, randomization and sponsor flags and completion horizons, drawn from the public ClinicalTrials.gov API and refreshed weekly. Entries summarize registered studies; no medical advice is given or implied.
Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)
Status
RECRUITING
Training Family
exercise (general)
Population Family
clinical population
Is Recruiting
true
Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)
The Training Science Trials Ledger follows ClinicalTrials.gov studies of exercise and training interventions, with training and population families, randomization and sponsor flags and completion horizons, drawn from the public ClinicalTrials.gov API and refreshed weekly. Entries summarize registered studies; no medical advice is given or implied.
Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)